{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:31:50Z","timestamp":1791570710893,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com.au","nursingoutlook.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing Outlook"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.outlook.2024.102248","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T03:07:25Z","timestamp":1722049645000},"page":"102248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Harm reduction nursing and the path toward developing best practice: Lessons from caring for people with xylazine-associated wounds in Philadelphia, PA"],"prefix":"10.1016","volume":"72","author":[{"given":"Catherine","family":"Tomson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Neuschatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Teixeira da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.outlook.2024.102248_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.25251\/skin.7.4.24","article-title":"Xylazine: An ulcerating addiction","volume":"7","author":"Ahuja","year":"2023","journal-title":"SKIN:\u00a0The Journal of Cutaneous Medicine"},{"issue":"3","key":"10.1016\/j.outlook.2024.102248_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jnu.12858","article-title":"The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review","volume":"55","author":"Alexander","year":"2023","journal-title":"Journal of Nursing Scholarship"},{"key":"10.1016\/j.outlook.2024.102248_bib3","unstructured":"AMA Principles of\u00a0Medical Ethics. (2017). Retrieved\u00a0March 21, 2024, from https:\/\/code-medical-ethics.ama-assn.org\/principles."},{"key":"10.1016\/j.outlook.2024.102248_bib4","unstructured":"American Nurses Association. (2015). Martha Turner, Marsha Fowler Code of\u00a0ethics for nurses with interpretive statements. American Nurses\u00a0Association.\u00a0https:\/\/www.nursingworld.org\/practice-policy\/nursing-excellence\/ethics\/code-of-ethics-for-nurses\/."},{"issue":"6","key":"10.1016\/j.outlook.2024.102248_bib5","first-page":"349","article-title":"Harm reduction: Compassionate care of persons with addictions","volume":"22","author":"Bartlett","year":"2013","journal-title":"Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses"},{"key":"10.1016\/j.outlook.2024.102248_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.outlook.2024.102248_bib7","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: A lesser-known entity","volume":"89","author":"Bishnoi","year":"2023","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1016\/j.outlook.2024.102248_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2373379920954843","article-title":"A compassionate framework for reducing harm in public health higher education: Implications for the COVID-19 pandemic","volume":"7","author":"Burke","year":"2021","journal-title":"Pedagogy in Health Promotion"},{"key":"10.1016\/j.outlook.2024.102248_bib9","unstructured":"Center for Drug Evaluation and Research,\u00a0U.S. Food and Drug Administration. (2022). FDA alerts health care\u00a0professionals of risks to patients exposed to xylazine in illicit drugs.\u00a0U.S. Food and Drug Administration,\u00a0https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-alerts-health-care-professionals-risks-patients-exposed-xylazine-illicit-drugs."},{"key":"10.1016\/j.outlook.2024.102248_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.outlook.2024.102248_bib11","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s11606-024-08693-y","article-title":"Relational harm reduction for internists: A call to action","volume":"39","author":"Hawk","year":"2024","journal-title":"Journal of General Internal Medicine"},{"issue":"6","key":"10.1016\/j.outlook.2024.102248_bib12","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.bja.2018.09.019","article-title":"Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: A systematic review and meta-analysis","volume":"122","author":"Higgins","year":"2019","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"10.1016\/j.outlook.2024.102248_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention"},{"issue":"2","key":"10.1016\/j.outlook.2024.102248_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jep.13941","article-title":"Clinical harm reduction in substance use: An ethics-oriented primer and critique for hospital-based providers","volume":"30","author":"Kontos","year":"2024","journal-title":"Journal of Evaluation in Clinical Practice"},{"issue":"2","key":"10.1016\/j.outlook.2024.102248_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/ACM.0000000000005467","article-title":"Stigma against patients with substance use disorders among health care professionals and trainees and stigma-reducing interventions: A systematic review","volume":"99","author":"Magnan","year":"2023","journal-title":"Academic Medicine: Journal of the Association of American Medical Colleges"},{"key":"10.1016\/j.outlook.2024.102248_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ADM.0000000000001245","article-title":"Xylazine-associated wounds: Clinical experience from a low-barrier wound care clinic in Philadelphia","volume":"18","author":"McFadden","year":"2023","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.outlook.2024.102248_bib17","unstructured":"National Harm Reduction Coalition.\u00a0(2020). Getting off: The basics\u00a0of safer injection. Retrieved\u00a0March 21, 2024, from\u00a0https:\/\/harmreduction.org\/issues\/safer-drug-use\/injection-safety-manual\/safer-injection-basics\/."},{"issue":"4","key":"10.1016\/j.outlook.2024.102248_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/NUR.0000000000000758","article-title":"Rising xylazine drug abuse in humans: A deep and lingering high with wounds, amputations, and death","volume":"37","author":"O\u2019Malley","year":"2023","journal-title":"Clinical Nurse Specialist"},{"issue":"6","key":"10.1016\/j.outlook.2024.102248_bib19","article-title":"The new stealth drug on the street: A narrative review of xylazine as a street drug","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.outlook.2024.102248_bib20","first-page":"1","article-title":"Unintentional drug overdose fatalities in Philadelphia, 2020","volume":"6","author":"Philadelphia Department of Public Health","year":"2021","journal-title":"CHART"},{"key":"10.1016\/j.outlook.2024.102248_bib21","unstructured":"Philadelphia Department\u00a0of Public Health. (2022a). Health alert: Risks of xylazine use and withdrawal\u00a0in people who use drugs in Philadelphia. Health Alert Network,\u00a0Philadelphia Department of Public\u00a0Health. Philadelphia Department of Public Health Health Information Portal,\u00a0https:\/\/hip.phila.gov\/document\/2524\/PDPH-HAN_Alert_1_Xylazine_03.16.2022.pdf\/."},{"key":"10.1016\/j.outlook.2024.102248_bib22","unstructured":"Philadelphia Department\u00a0of Public Health. (2022b). Health update: Xylazine (tranq) exposure among\u00a0people who use substances in Philadelphia. Health Alert Network, Philadelphia Department of Public Health. Philadelphia Department of Public Health Health Information Portal,\u00a0https:\/\/hip.phila.gov\/document\/3154\/PDPH-HAN_Update_13_Xylazine_12.08.2022.pdf\/."},{"key":"10.1016\/j.outlook.2024.102248_bib23","unstructured":"Philadelphia Department\u00a0of Public Health, Division of Substance Use Prevention and Harm Reduction.\u00a0(2024). Recommendations for caring for individuals with xylazine-associated\u00a0wounds.\u00a0U.S. Food and Drug Administration,\u00a0https:\/\/static1.squarespace.com\/static\/6386664d01197028e20ce9e1\/t\/65a975737ac9c41ea8eabc2f\/1705604468670\/Recommendations_for_Caring_for_People_with_Xylazine-Associated_Wounds_1.12.24.pdf."},{"key":"10.1016\/j.outlook.2024.102248_bib24","unstructured":"Prevention Point. (2022). Prevention point housing\u00a0celebrates one year at Beacon house. Retrieved March 22, 2024, from\u00a0https:\/\/ppponline.org\/blog\/prevention-point-housing-celebrates-one-year-beacon-house."},{"key":"10.1016\/j.outlook.2024.102248_bib25","unstructured":"Substance Abuse and\u00a0Mental Health Administration. (2023).\u00a0Harm reduction framework. Center for\u00a0Substance Abuse Prevention.\u00a0https:\/\/www.samhsa.gov\/find-help\/harm-reduction\/."},{"key":"10.1016\/j.outlook.2024.102248_bib26","unstructured":"Substance\u00a0Use Philly. (2023).\u00a0Philadelphia\u2019s Changing\u00a0Drug Supply\u2014Test Program. Retrieved June 10, 2024, from\u00a0https:\/\/www.substanceusephilly.com\/drugsupply."},{"key":"10.1016\/j.outlook.2024.102248_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdcr.2023.04.016","article-title":"Severe cutaneous ulcerations secondary to xylazine (tranq): A case series","volume":"36","author":"Wei","year":"2023","journal-title":"JAAD Case Reports"},{"issue":"4","key":"10.1016\/j.outlook.2024.102248_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3928\/02793695-20220309-01","article-title":"Reimagining nursing through harm reduction","volume":"60","author":"Woody","year":"2022","journal-title":"Journal of Psychosocial Nursing and Mental Health Services"},{"issue":"1","key":"10.1016\/j.outlook.2024.102248_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12954-023-00879-7","article-title":"Reducing the harms of xylazine: Clinical approaches, research deficits, and public health context","volume":"20","author":"Zagorski","year":"2023","journal-title":"Harm Reduction Journal"}],"container-title":["Nursing Outlook"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029655424001416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0029655424001416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T17:14:59Z","timestamp":1729185299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0029655424001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0029655424001416"],"URL":"https:\/\/doi.org\/10.1016\/j.outlook.2024.102248","relation":{},"ISSN":["0029-6554"],"issn-type":[{"value":"0029-6554","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harm reduction nursing and the path toward developing best practice: Lessons from caring for people with xylazine-associated wounds in Philadelphia, PA","name":"articletitle","label":"Article Title"},{"value":"Nursing Outlook","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.outlook.2024.102248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102248"}}